Evidence map›Paper›PMID 28843191›Full record

ReviewCurrent opinion in biotechnology2018

A short history of RubisCO: the rise and fall (?) of Nature's predominant CO

Tobias J Erb, Jan Zarzycki

Abstract readReview
In one paragraph

Review in Current opinion in biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed.

  1. Article
  2. A clean slate for Rubisco engineering.The Plant journal : for cell and molecular biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Solar Air-to-Fuel Technologies for a Circular Carbon Economy.Journal of the American Chemical Society · 2026
    Review
  8. Review
  9. Microbial metal physiology: ions to ecosystems.Nature reviews. Microbiology · 2025
    Review
  10. Rubisco is slow across the tree of life.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. In vivo directed evolution of an ultrafast Rubisco from a semianaerobic environment imparts oxygen resistance.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. In-cell Structure and Variability of Pyrenoid Rubisco.bioRxiv : the preprint server for biology · 2025
    Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tobias J ErbMax Planck Institute for Terrestrial Microbiology, Department of Biochemistry and Synthetic Metabolism, Karl-von-Frisch-Str. 10, 35043 Marburg, Germany. Electronic address: toerb@mpi-marburg.mpg.de.
Jan ZarzyckiMax Planck Institute for Terrestrial Microbiology, Department of Biochemistry and Synthetic Metabolism, Karl-von-Frisch-Str. 10, 35043 Marburg, Germany.

Funding

European Research Council 637675
6 · The paper itself

Abstract

Ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO) is arguably one of the most abundant proteins in the biosphere and a key enzyme in the global carbon cycle. Although RubisCO has been intensively studied, its evolutionary origins and rise as Nature's most dominant carbon dioxide (CO

Indexed as

Carbon CycleAutotrophic ProcessesBiological EvolutionCarbon DioxidePhylogenyRibulose-Bisphosphate CarboxylaseCarbon DioxideRibulose-Bisphosphate Carboxylase

Identifiers

PMID28843191
PMCPMC7610757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.